| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Genotyping frequently is used to distinguish recrudescent from new infections in antimalarial drug efficacy trials, but methodology and interpretation of results have not been standardized. We compared the utility of polymorphisms within 3 Plasmodium falciparum genes during a longitudinal trial in Kampala, Uganda. Merozoite surface protein-1 (msp-1) and merozoite surface protein-2 (msp-2) revealed greater diversity than glutamate-rich protein. Genotypes based on msp-1, msp-2, and all 3 genes combined were compared for 394 initial and subsequent isolates. Classification of most episodes as due to recrudescence or reinfection was straightforward. In 24% (msp-1), 16% (msp-2), and 62% (3 genes combined) of samples, subsequent episodes contained identical and new alleles, however. Our analysis suggested that such episodes should be classified as reinfections and not recrudescence. Comparing the 3 studied genes, msp-2 results were most accurate, and analysis of this single gene effectively distinguished recrudescence from reinfection in our study population.
Received July 26, 2002. Accepted for publication October 21, 2002.
Acknowledgments: We thank the clinical study team of B.M. Karakire, Marx Dongo, Sam Nsobya, Moses Kiggundu, Christopher Bongole, Regina Nakafero, Bridget K. Nzarubara, Pauline Byakika, and Sarah Kibirango; Sarah Staedke, for reviewing the manuscript; community leaders from the Kawempe Division of Kampala; and the study participants and their parents or guardians.
Financial support: This work was supported by the Fogarty International Center/National Institutes of Health (TW00007, TW01506, and AI43301), the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), and the Doris Duke Charitable Foundation Clinical Research Fellowship.
Authors’ addresses: Adithya Cattamanchi, Philip J. Rosenthal, and Grant Dorsey, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, P.O. Box 0811, San Francisco, CA 94143, Telephone: 415-206-8687, Fax: 415-648-8425. Daniel Kyabayinze, Department of Biochemistry, Makerere University Medical School, P.O. Box 7072, Kampala, Uganda. Alan Hubbard, Department of Biostatistics, School of Public Health, University of California, Berkeley, 735 University Hall, Berkeley, CA 94720, Telephone: 510-642-8365, Fax: 510-642-5815.
Reprint requests: Grant Dorsey, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, P.O. Box 0811, San Francisco, CA 94143, Telephone: 415-206-8687, Fax: 415-648-8425, E-mail: grantd{at}itsa.ucsf.edu
This article has been cited by other articles:
|
|
 |
|
  M. K. Laufer, A. A. Djimde, and C. V. Plowe Monitoring and Deterring Drug-Resistant Malaria in the Era of Combination Therapy Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 160 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Marfurt, I. Mueller, A. Sie, P. Maku, M. Goroti, J. C. Reeder, H.-P. Beck, and B. Genton Low Efficacy of Amodiaquine or Chloroquine Plus Sulfadoxine-Pyrimethamine against Plasmodium falciparum and P. vivax Malaria in Papua New Guinea Am J Trop Med Hyg, November 1, 2007; 77(5): 947 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Laufer, J. J. G. van Oosterhout, P. C. Thesing, F. K. Dzinjalamala, T. Hsi, L. Beraho, S. M. Graham, T. E. Taylor, and C. V. Plowe Malaria Treatment Efficacy among People Living with HIV: The Role of Host and Parasite Factors Am J Trop Med Hyg, October 1, 2007; 77(4): 627 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Greenhouse, C. Dokomajilar, A. Hubbard, P. J. Rosenthal, and G. Dorsey Impact of Transmission Intensity on the Accuracy of Genotyping To Distinguish Recrudescence from New Infection in Antimalarial Clinical Trials Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3096 - 3103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Nsobya, C. Dokomajilar, M. Joloba, G. Dorsey, and P. J. Rosenthal Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda Antimicrob. Agents Chemother., August 1, 2007; 51(8): 3023 - 3025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. HOPKINS, W. KAMBALE, M. R. KAMYA, S. G. STAEDKE, G. DORSEY, and P. J. ROSENTHAL COMPARISON OF HRP2- AND pLDH-BASED RAPID DIAGNOSTIC TESTS FOR MALARIA WITH LONGITUDINAL FOLLOW-UP IN KAMPALA, UGANDA Am J Trop Med Hyg, June 1, 2007; 76(6): 1092 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. DIALLO, C. SUTHERLAND, I. NEBIE, A. T. KONATE, R. ORD, H. POTA, C. ROPER, E. ILBOUDO-SANOGO, B. M. GREENWOOD, and S. N. COUSENS SUSTAINED USE OF INSECTICIDE-TREATED CURTAINS IS NOT ASSOCIATED WITH GREATER CIRCULATION OF DRUG-RESISTANT MALARIA PARASITES, OR WITH HIGHER RISK OF TREATMENT FAILURE AMONG CHILDREN WITH UNCOMPLICATED MALARIA IN BURKINA FASO Am J Trop Med Hyg, February 1, 2007; 76(2): 237 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. GREENHOUSE, A. MYRICK, C. DOKOMAJILAR, J. M. WOO, E. J. CARLSON, P. J. ROSENTHAL, and G. DORSEY VALIDATION OF MICROSATELLITE MARKERS FOR USE IN GENOTYPING POLYCLONAL PLASMODIUM FALCIPARUM INFECTIONS Am J Trop Med Hyg, November 1, 2006; 75(5): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. DOKOMAJILAR, Z. M. LANKOANDE, G. DORSEY, I. ZONGO, J.-B. OUEDRAOGO, and P. J. ROSENTHAL Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in burkina faso. Am J Trop Med Hyg, July 1, 2006; 75(1): 162 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dokomajilar, S. L. Nsobya, B. Greenhouse, P. J. Rosenthal, and G. Dorsey Selection of Plasmodium falciparum pfmdr1 Alleles following Therapy with Artemether-Lumefantrine in an Area of Uganda where Malaria Is Highly Endemic. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1893 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. MYRICK, E. LEEMANN, C. DOKOMAJILAR, H. HOPKINS, G. DORSEY, M. R. KAMYA, and P. J. ROSENTHAL Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda. Am J Trop Med Hyg, May 1, 2006; 74(5): 758 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. AYALA, A. G. LESCANO, R. H. GILMAN, M. CALDERON, V. V. PINEDO, H. TERRY, L. CABRERA, and J. M. VINETZ POLYMERASE CHAIN REACTION AND MOLECULAR GENOTYPING TO MONITOR PARASITOLOGICAL RESPONSE TO ANTI-MALARIAL CHEMOTHERAPY IN THE PERUVIAN AMAZON Am J Trop Med Hyg, April 1, 2006; 74(4): 546 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. EGGENA, H. HOPKINS, B. BARUGAHARE, M. OKELLO, F. SSALI, P. MUGYENYI, P. J. ROSENTHAL, H. CAO, and G. DORSEY CD4 T CELL ACTIVATION AS A PREDICTOR FOR TREATMENT FAILURE IN UGANDANS WITH PLASMODIUM FALCIPARUM MALARIA Am J Trop Med Hyg, January 1, 2006; 74(1): 41 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. ZONGO, G. DORSEY, N. ROUAMBA, C. DOKOMAJILAR, M. LANKOANDE, J.-B. OUEDRAOGO, and P. J. ROSENTHAL AMODIAQUINE, SULFADOXINE-PYRIMETHAMINE, AND COMBINATION THERAPY FOR UNCOMPLICATED FALCIPARUM MALARIA: A RANDOMIZED CONTROLLED TRIAL FROM BURKINA FASO Am J Trop Med Hyg, November 1, 2005; 73(5): 826 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. MENARD, M. D. MATSIKA-CLAQUIN, D. DJALLE, F. YAPOU, A. MANIRAKIZA, V. DOLMAZON, J. SARDA, and A. TALARMIN ASSOCIATION OF FAILURES OF SEVEN-DAY COURSES OF ARTESUNATE IN A NON-IMMUNE POPULATION IN BANGUI, CENTRAL AFRICAN REPUBLIC WITH DECREASED SENSITIVITY OF PLASMODIUM FALCIPARUM Am J Trop Med Hyg, September 1, 2005; 73(3): 616 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. SLATER, M. KIGGUNDU, C. DOKOMAJILAR, M. R. KAMYA, N. BAKYAITA, A. TALISUNA, P. J. ROSENTHAL, and G. DORSEY DISTINGUISHING RECRUDESCENCES FROM NEW INFECTIONS IN ANTIMALARIAL CLINICAL TRIALS: MAJOR IMPACT OF INTERPRETATION OF GENOTYPING RESULTS ON ESTIMATES OF DRUG EFFICACY Am J Trop Med Hyg, August 1, 2005; 73(2): 256 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. NYACHIEO, C. VAN OVERMEIR, T. LAURENT, J.-C. DUJARDIN, and U. D'ALESSANDRO PLASMODIUM FALCIPARUM GENOTYPING BY MICROSATELLITES AS A METHOD TO DISTINGUISH BETWEEN RECRUDESCENT AND NEW INFECTIONS Am J Trop Med Hyg, July 1, 2005; 73(1): 210 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. NGRENNGARMLERT, J. J. KWIEK, D. D. KAMWENDO, K. RITOLA, R. SWANSTROM, C. WONGSRICHANALAI, R. S. MILLER, W. ITTARAT, and S. R. MESHNICK MEASURING ALLELIC HETEROGENEITY IN PLASMODIUM FALCIPARUM BY A HETERODUPLEX TRACKING ASSAY Am J Trop Med Hyg, June 1, 2005; 72(6): 694 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. BAKYAITA, G. DORSEY, A. YEKA, K. BANEK, S. G. STAEDKE, M. R. KAMYA, A. TALISUNA, F. KIRONDE, S. NSOBYA, A. KILIAN, et al. SULFADOXINE-PYRIMETHAMINE PLUS CHLOROQUINE OR AMODIAQUINE FOR UNCOMPLICATED FALCIPARUM MALARIA: A RANDOMIZED, MULTISITE TRIAL TO GUIDE NATIONAL POLICY IN UGANDA Am J Trop Med Hyg, May 1, 2005; 72(5): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. PARIKH, G. DORSEY, and P. J. ROSENTHAL HOST POLYMORPHISMS AND THE INCIDENCE OF MALARIA IN UGANDAN CHILDREN Am J Trop Med Hyg, December 1, 2004; 71(6): 750 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. DORSEY, C. DOKOMAJILAR, M. KIGGUNDU, S. G. STAEDKE, M. R. KAMYA, and P. J. ROSENTHAL PRINCIPAL ROLE OF DIHYDROPTEROATE SYNTHASE MUTATIONS IN MEDIATING RESISTANCE TO SULFADOXINE-PYRIMETHAMINE IN SINGLE-DRUG AND COMBINATION THERAPY OF UNCOMPLICATED MALARIA IN UGANDA Am J Trop Med Hyg, December 1, 2004; 71(6): 758 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. DORSEY, A. F. GASASIRA, R. MACHEKANO, M. R. KAMYA, S. G. STAEDKE, and A. HUBBARD THE IMPACT OF AGE, TEMPERATURE, AND PARASITE DENSITY ON TREATMENT OUTCOMES FROM ANTIMALARIAL CLINICAL TRIALS IN KAMPALA, UGANDA Am J Trop Med Hyg, November 1, 2004; 71(5): 531 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. O. Talisuna, P. Bloland, and U. D'Alessandro History, Dynamics, and Public Health Importance of Malaria Parasite Resistance Clin. Microbiol. Rev., January 1, 2004; 17(1): 235 - 254. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
